ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS.

摘要

The invention refers to the use of oncostatin M (OSM), an OSM receptor (OSMR) agonist, or a combination of OSM or of an OSMR agonist with an interferon of type I (IFN type I), in the manufacture of a medicament to increase the immunostimulatory activity of epithelial cells in a human.